What is QuantrolOx?
QuantrolOx, based in Oxford, England, is a notable player in the AI-driven quantum computing technology and software provision space. The company is focused on developing and delivering solutions that leverage the power of quantum mechanics for computational advantage. This strategic positioning places QuantrolOx at the forefront of a rapidly evolving technological frontier, aiming to solve complex problems currently intractable for classical computing.
How much funding has QuantrolOx raised?
QuantrolOx has raised a total of $16.1M across 4 funding rounds:
Multiple Rounds
$12.4M
Angel/Seed
$3.7M
Angel/Seed (2022): $1.9M with participation from Nielsen Ventures, Remus Capital, Hermann Hauser, Laurent Caraffa, Hoxton Ventures, and Voima Ventures
Grant (2022): $2.5M led by The European Innovation Council
Other Financing Round (2022): $8M supported by The European Innovation Council
Angel/Seed (2023): $3.7M featuring Hoxton Ventures, Voima Ventures, 2xN, Nielsen, Oxford Sciences Enterprises, and Serendipity Capital
Key Investors in QuantrolOx
Hoxton Ventures
Hoxton Ventures is an early-stage venture capital firm based in London that invests in European technology startups with the potential for global scale. They focus on disruptive or category-inventing companies and have a history of early investment in major tech successes.
Voima Ventures
Voima Ventures is dedicated to funding leading scientific deep tech ventures in the Nordics and Baltics, aiming to address significant global challenges through science-driven innovation. They support founders in scaling solutions that benefit people, the planet, and industry.
Oxford Sciences Enterprises
Oxford Science Enterprises is an investment company established to found, fund, and build transformational businesses in partnership with the University of Oxford, focusing on deep tech innovations.
What's next for QuantrolOx?
With substantial backing and a clear focus on enterprise-level applications, QuantrolOx is poised for significant growth and development. The recent capital infusion, characterized as a major strategic investment, suggests a trajectory towards scaling operations, accelerating research and development, and potentially forging key industry partnerships. This funding will likely enable QuantrolOx to further refine its quantum computing technologies and expand its market reach, solidifying its position in the competitive deep tech landscape.
See full QuantrolOx company page